IMVT vs PLD · $2.90B cap vs P/E 27, rev $2.25B
Immunovant Inc (IMVT) versus Prologis Inc (PLD) — a side-by-side from cached financials, not a winner call.
Immunovant Inc (IMVT) is a biotechnology company listed on US.
Prologis Inc (PLD) is a reit - industrial company listed on US.
IMVT does not have a complete income-statement cache yet.
Latest reported PLD revenue for 2025-12-31 was $2.25B. Net income was $1.48B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
IMVT currently screens at market cap $2.90B. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
Not investment advice. Open the IMVT and PLD stock pages for the full models.
Not investment advice.